Biotech Manufacturing Strategies: Quality, Scalability, and Control – Insights from Dr. Ulrich Rümenapp, Bayer AG

This exclusive interview with Dr. Ulrich Rümenapp, Senior Biotech Program Lead at Bayer AG, delves into the key strategies for biotech manufacturing success. With biotech manufacturing facing new challenges and opportunities, Dr. Rümenapp covers essential topics, including:

• Prioritising Quality in Biotech Manufacturing: Learn how to integratequality assurance and quality control from the earliest stages of product development to ensure safety and compliance.
• Top Dos and Don’ts for Biotech Partnerships: Explore Dr. Rümenapp’s recommendations for pharma companies deciding between in-house manufacturing and external partnerships.
• Balancing Cost, Control, and Scalability: Understand the full cost of ownership and the value of flexibility when making critical manufacturing decisions.
• Future-Proofing Biotech Manufacturing: Discover Dr. Rümenapp’s advice for maintaining adaptability in the face of rapid technological advancements.
• Leveraging Specialised Expertise in Partnerships: Learn the importance of maintaining internal capabilities while partnering with CMOs that offer specialised knowledge in areas like gene editing.

For pharma professionals involved in biotech manufacturing, this interview offers actionable insights on balancing quality, cost, and control. Gain expert perspectives on how to leverage specialised partnerships, maintain compliance, and navigate the complexities of biotech production for future-ready manufacturing strategies.